Quarterly report pursuant to Section 13 or 15(d)

Net (Loss) Income Per Share of Common Stock - Schedule of Antidilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding (Detail)

v3.20.1
Net (Loss) Income Per Share of Common Stock - Schedule of Antidilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding (Detail) - shares
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities outstanding excluded from the computation of diluted weighted average shares 4,851,784 4,007,185
Employee Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities outstanding excluded from the computation of diluted weighted average shares 1,818,588 908,474
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities outstanding excluded from the computation of diluted weighted average shares 3,033,196 3,098,711